Multiple Myeloma: evidence-based decision making using randomized controlled trials
The thesis was published by
Tan, Chrissy,
in October 2022,
Erasmus University Rotterdam.
Abstract:
This dissertation describes how phase 3 randomised control trial data can be utilized to support evidence-based decision making for determining the cost-effectiveness of treatment sequences in multiple myeloma. It also emphasizes that health technology assessment agencies must be aware of different methods of data synthesis, which result in slightly different rankings of treatments.